Status:
RECRUITING
Loupe-Based Intraoperative Fluorescence Imaging
Lead Sponsor:
Guoqiang Yu
Collaborating Sponsors:
Bioptics Technology LLC
National Cancer Institute (NCI)
Conditions:
Glioblastoma Multiforme
Anaplastic Astrocytoma
Eligibility:
All Genders
18-90 years
Brief Summary
Glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA) are the most common primary malignant brain tumors. Survival of patients with these brain tumors is directly related to the extent of rese...
Detailed Description
This is a prospective, observational study to compare the measurement accuracies of a wearable loupe-based device and the large microscope against the gold standards of postoperative histopathological...
Eligibility Criteria
Inclusion
- adults with brain malignant gliomas undergoing resection
- at least 18 years of age
- able to understand the consent
Exclusion
- pregnant women
- under 18 years of age
- patients undergoing emergency surgery
- inability to give consent due to dysphagia or language barrier
Key Trial Info
Start Date :
November 17 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04780009
Start Date
November 17 2017
End Date
June 1 2026
Last Update
July 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky
Lexington, Kentucky, United States, 40536